Abstract
Studies on diiron dithiolato complexes have proven fruitful for modeling the active site of the [FeFe]-hydrogenases. Here we present a departure from the classical Fe2S2 motif by examining the viability of Fe2N2 butterfly compounds as functional models for the diiron active site of [FeFe]-hydrogenases. Derivatization of Fe2(BC)(CO)6 (1, BC = benzo-[c]-cinnoline) with PMe3 affords Fe2(BC) (CO)4(PMe3)2, which subsequently undergoes protonation at the Fe–Fe bond. The hydride [(μ-H)Fe2(BC)(CO)4(PMe3)2]PF6 was characterized crystallographically as the C2v isomer. It represents a rare example of a hydrido diiron complex that exists as observable isomers, depending on the location of the phosphine ligands – diapical and apical–basal. This hydride catalyzes the electrochemical reduction of protons.
Keywords: Fe complexes, Metal hydride, Hydrogenase, Electrocatalysis
In recent years, many compounds of the type Fe2(S-R)2(CO)4L2 have been prepared and examined as structural and functional models for the active site of [FeFe]-hydrogenases. Particular emphasis has been placed on variations of L, especially tertiary phosphines [1–3], but also isocyanides [4,5], N-heterocyclic carbenes [6–9], and cyanide [10–13]. While much effort has focused on functionalizing the dithiolate ligand [14–20], relatively little work has examined the possibility of replacing the thiolates with other bridging groups [21]. Best and coworkers demonstrated that the corresponding phosphides Fe2(PR2)2(CO)6 and [Fe2(PR2)2(CO)6H]− are effective catalysts for hydrogen evolution [22].
Incentives for broadening the range of bridging ligands include changing the steric profile of the catalysts, altering the susceptibility of the bridge toward electrophilic attack (important since these catalysts function in acidic media), incorporating functionality, and manipulating the electronic character (basicity, E1/2) of the metals. Naturally, a fundamental motivation for investigating new bridging ligands is to elucidate the elementary design rules that will lead to greater mechanistic insight and, ultimately, a deeper understanding of hydrogenogenesis.
Approximately 15 nitrogenous bridges are known to link pairs of iron centers, giving complexes of the general formula Fe2(NR1,2)2(CO)6 (Scheme 1). Many of the complexes were first reported in the 1960s and 1970s in an era where the interactions of nitrene-forming reagents and metal carbonyls were first systematized. We selected one representative of this series, Fe2(BC)(CO)6 [23–26] (1, where BC = benzo-[c]-cinnoline, N2C12H8, Scheme 1) to examine as a candidate for a new model class for [FeFe]-hydrogenases. In a structural sense, 1 differs significantly from the well-studied Fe2(SR)2(CO)6 motif. For this reason we felt that its properties would test most demandingly the scope of the hydrogenase behavior of the Fe2(μ-X)2Ln systems (L = CO, donor ligands). This report summarizes these results, which indeed demonstrate the prospect that many nitrogenous bridging ligands could be applied to the modeling of hydrogenases.
Scheme 1.

Generalized structures of azodiiron carbonyl complexes and the structure of 1.
Compound 1 was prepared using the original method, using Fe3(CO)12 in place of Fe(CO)5 [27]. As for other donor ligands [26,28], PMe3 displaced two of the CO ligands in 1 to afford the red-colored Fe2(BC)(CO)4(PMe3)2 (2) (Eq. (1)).1 1 is noticeably more electrophilic than analogous diiron dithiolates; disubstitution of the dithiolate system requires more demanding conditions (e.g. 80°C for 9 h vs. 25 °C for 1.5 h). The BC ligand is apparently robustly attached since it was not displaced by the highly nucleophilic PMe3 ligand.
| (1) |
Encouraged by the stability of the BC ligand towards nucleophiles, we examined cyanide derivatives. Treatment of 1 with two equiv. Et4NCN indeed afforded the dicyanide complex [Fe2(BC)(CO)4(CN)2]2− as indicated by IR spectroscopy (MeOH: νCN = 2106; νCO = 2039, 2020, 1998, 1968, 1938, 1879, 1814 cm−1). The appearance of numerous carbonyl bands is attributed to the presence of multiple isomers in solution, as also observed in phosphine derivatives discussed below. The dicyanide product proved to be unstable, even in the solid state. A stable monocyanide derivative was prepared via the reaction of 1 with KN(SiMe3)2 [11]. Similarly, treatment of 1 with Me3NO gave the MeCN complex Fe2(BC)(CO)5(MeCN) (νCO = 2043, 2030, 1976, 1964, 1913 cm−1) [29], which was found to react with Et4NCN to afford Et4N[Fe2(BC) (CO)5(CN)], as indicated by IR spectroscopy and ESI-MS.2
It was of interest to determine if the diiron azo system 2 could be protonated at the Fe–Fe bond and, if so, would the resulting hydride electrocatalyze proton reduction, analogous to the reactivity observed in Fe2(SR)2 systems [29–31]. Indeed, we found that HCl effected protonation at the Fe–Fe bond of 2, thereby forming a rare example of a (μ-hydrido)diiron azo system, [2H]+.3 The complex was isolated as its salt from H2O/MeOH solution [32]. Interestingly, protonation of 2 afforded two solution isomers (Scheme 2), as indicated by doublet-of-doublet (unsymmetrical isomer) and triplet (symmetrical isomer) 1H NMR signals for the hydride, in a ratio of 1.0:1.8, respectively. In contrast, protonation of Fe2(S2C2H4)(CO)4(PMe3)2 and Fe2(S2C3H6)(CO)4(PMe3)2 gives only a trans-dibasal isomer, even at low temperatures [32]. Also, (μ-H)Fe2(S2C3H6)(CO)4(CN)(PMe3) exists as only one predominant isomer [1]. The only case where multiple isomers have been detected was in [(μ-H)Fe2(S2C3H6)(CO)4(CN)2]−, which was not isolated but characterized in solution [32].
Scheme 2.

Protonation reaction of 2 to form [2H]+.
The structure of the major (symmetrical) isomer was confirmed crystallographically (Fig. 1). Both PMe3 ligands were found to be in the apical position, i.e. trans to the hydride. For comparison, diiron dithiolate bis(phosphine) complexes rarely adopt a diapical structure, e.g. Fe2 (S2C3H6)(CO)4(PMe2Ph)2 [3], and examples are not known of protonated (i.e. μ-hydride) species exhibiting diapical phosphine ligands.
Fig. 1.
Two views of the structure of the cation in [(μ-H)Fe2(N2C12H8)(CO)4(PMe3)2]PF6 with thermal ellipsoids set at the 50% probability level.
Selected parameters derived from crystallographic measurements of [2H]PF6 and Darensbourg’s [(μ-H)Fe2 (S2C2H4)(CO)4(PMe3)2]PF6 [2], featuring trans-dibasal phosphine ligands, are listed in Table 1. Comparing these data, significant differences are observed only for the Fe–E (where E = N or S) distances and angles. Similar to other diiron azo complexes, [2H]+ exhibits shorter distances to iron than do thiolate ligands. The most striking difference between the Fe2N2 and Fe2S2 butterfly cores is the E–Fe–E angle, wherein the N–Fe–N angle is ~40° more acute than the S–Fe–S angle. The short Fe–N distances and the small N–Fe–N angles are compensated by expanded Fe–N–Fe angles, thereby minimizing any effect on the Fe–Fe distance. Indeed, all Fe-ligand distances are virtually identical for the azo- and dithiolato-bridged systems. Thus, the structural similarities between the azo and dithiolate systems indicate the promise of a still wider range of bridging ligands in catalysts that effect hydrogenogenesis.
Table 1.
Selected distances (Å) and angles (deg) for [2H]PF6 and [(μ-H)Fe2(S2C2H4)(CO)4(PMe3)2]PF6
| [2H]PF6 | [μ-H)Fe2(S2C2H4)(CO)4(PMe3)2]PF6 | ||
|---|---|---|---|
| Fe–Fe | 2.5599(8) | 2.5742(13) | Fe–Fe |
| Fe–H | 1.62(3) | 1.69(6) | Fe–H |
| Fe–Papical | 2.2362(12) | 2.2392(16) | Fe–Pbasal |
| Fe–C | 1.774(4) | 1.770(6) | Fe–C |
| Fe–N | 1.927(5) | 2.2562(6) | Fe–S |
| N–N | 1.399(4) | 2.924 | S–S |
| Fe–N–Fe | 82.99(11) | 69.57(5) | Fe–S–Fe |
| N–Fe–N | 42.53(11) | 80.78(6) | S–Fe–S |
| C–Fe–P | 90.46(15) | 94.8(4) | C–Fe–P |
We confirmed that [2H]+ catalyzes hydrogen evolution from p-toluenesulfonic acid (HOTs) via experiments conducted electrochemically. The cathodic current at ~−1.1 V vs. Ag/AgCl grew proportionally with additional equivalents of HOTs until ca. 4 equiv., at which stage [2H]+ decomposes (Fig. 2). The overpotential of electrocatalysis is virtually identical to that observed for diiron dithiolate systems under the same reaction conditions.
Fig. 2.

Cyclic voltammagrams vs. Ag/AgCl of 2 + x HOTs, x = 0–3 equiv., in MeCN with Bu4NPF6.
The substitutional behavior of the diiron azo complexes bears both similarities and differences with the more commonly studied dithiolate complexes. Both the azo- and thiolato- bridged species undergo a maximum of disubstitution with conventional unidentate ligands. The Fe2N2 system differs significantly from the well-studied Fe2(SR)2 system in terms of the rates of substitution and the isomeric content. As shown by Ellgen, the activation enthalpies for substitution of Fe2(BC)(CO)6 are ca. 2 kcal/mol more favorable relative to the corresponding dithiolato complexes [26,33]. It is significant that [(μ-H)Fe2(S2CnH2n)(CO)4 (PMe3)2]+ exists as only one isomer, but the BC analogue also features the diapical isomer. This difference highlights the significant influence of the steric properties of the bridging ligands on the apical coordination sites trans with respect to the Fe–Fe bond. This steric interaction is greater when the two iron centers are bridged by three ligands, as in complexes of the type [Fe2(SR)2(μ-X)L6]z (X = CO, H).
Taking advantage of the fact that [2H]PF6 crystallizes as a single isomer, we dissolved crystals of this compound in CD3CN at 0 °C to obtain the spectrum of this isomer. Indeed the solution exhibited one triplet in the hydride region of the 1H NMR spectrum. Over a period of minutes, this symmetrical complex isomerized via a 1st order process to an equilibrium mixture of symmetrical and unsymmetrical isomers. The stability of multiple isomers is consistent with the minimal steric pressure exerted by the planar BC ligand on the ligands that occupy the apical sites. As we have discussed previously, protonation narrows the distance between apical ligands and the bridging ligand, which usually destabilizes large apical ligands [34]. Another case where multiple isomers of a substituted μ-hydride have been observed is [(μ-H)Fe2(S2C3H6)(CO)4(CN)2]−, which features the small cyanide ligands in the apical position.
In summary, a new class of [FeFe]-hydrogenase active site models, based on a Fe2N2 butterfly core, has been established. These diiron azo compounds catalyze the electrochemical reduction of protons to H2. Although the catalysts based on BC are less robust than the dithiolate complexes, there is considerable scope for improvement. A wide range of azo-bridged diiron complexes is known [24,27,35–37], including ligands such as chloro-substituted BC [27], the sterically imposing 2,3-diazabicyclo[2.2.1]hept- 2-ene (DBH) [26,38], and PhN(X)NPh (where X = CO, SO2) [39–41].
Supplementary Material
Supplementary data associated with this article can be found, in the online version, at doi:10.1016/j.jinorgbio.2007. 05.005.
Acknowledgments
This work was supported by the United States National Institutes of Health.
Footnotes
Fe2(N2C12H8)(CO)4(PMe3)2, 2. A red solution of 500 mg (1.09 mmol) of 1 in 25 mL of toluene was treated with approximately 700 μL (6.76 mmol) of PMe3. IR measurements indicated that the reaction was complete within 1.5 h at room temperature. The resulting deeper red solution was filtered through a plug of Celite and evaporated in vacuo. The product was precipitated twice from a toluene solution by addition of hexanes at 0 °C, washed twice with 5 mL of hexanes at 0 °C, and dried in vacuo. Yield: 317 mg (52%). 1H NMR (500 MHz, CD3CN): δ 7.757–7.739, 7.166–7.133, 7.068–7.050 (m, m, m, 8H, N2C12H8), 1.065–1.049 (d, 18H, P(CH3)3)2. 31P NMR (202 MHz, CD3CN): δ 13.725 (s). IR (toluene): νCO = 1984 (vs), 1976 (m), 1938 (s), 1915 (vs), 1900 (m), 1887 (w) cm−1. FD-MS: m/z = 556.0 (100%, M+). Anal. Calcd. for C22H26Fe2N2O4P2: C, 47.52; H, 4.71; N, 5.04. Found: C, 47.37; H, 4.64; N, 5.03.
Et4N[Fe2(N2C12H8)(CO)5(CN)]. A slurry of 150 mg (0.326 mmol) of 1 in 10 mL of MeCN was treated with a solution of 24 mg (0.326 mmol) of Me3NO in 5 mL of MeCN. A hazy, deep red solution formed within 5 min. Treatment of the Fe2(N2C12H8)(CO)5(MeCN) solution (νCO = 2043, 2030, 1976, 1964, 1913 cm−1) with a solution of 51 mg (0.326 mmol) of Et4NCN in 3 mL of MeCN resulted in a deepening of the red color. After 1 h, solvent was removed in vacuo. The product was purified by precipitation from concentrated THF solutions by addition of hexanes. The resulting oil solidified upon trituration with hexanes. Yield: 132 mg (69%). IR (MeCN): νCN = 2093 (w), νCN = 2025 (vs), 1960 (vs), 1945 (vs), 1902 (m) cm−1.
[(μ-H)Fe2(N2C12H8)(CO)4(PMe3)2]PF6, [2H]PF6. A slurry of 113 mg (0.203 mmol) of 2 in 2 mL of MeOH was treated with 1.5 mL of concentrated HCl to afford an orange–red solution within 5 min. After 1 h, the solution was treated with 2 mL of saturated aqueous NH4PF6, which precipitated an orange solid. The solid was washed with H2O, dried in vacuo, and washed with Et2O (3 × 5 mL). The product was recrystallized three times from CH2Cl2 solution by addition of hexane, washed with C6H14, and dried in vacuo. Yield: 98 mg (69%). Single crystals were grown from CH2Cl2/C6H14. Anal. Calcd. for C22H27F6Fe2N2O4P3: C, 37.64; H, 3.88; N, 3.99. Found: C, 37.42; H, 3.97; N, 3.94. 1H NMR (500 MHz, CD3CN): δ 8.061–8.042, 7.520–7.468, 7.306–7.287 (m, m, m, 8H, N2C12H8), 1.637 (d, 2H, JPH = 10.5 Hz, unsym P(CH3)3), 1.059 (d, 2H, JPH = 10.9 Hz, unsym P(CH3)3), 1.014 (d, 18H, JPH = 10.5 Hz, sym P(CH3)3)2, −15.479 (dd, 0.09H, JPH = 8Hz, JP′H = 26.5Hz, unsym (μ-H)Fe2), −15.621 (t, 0.73H, JPH = 9 Hz, sym (μ-H)Fe2). 31P NMR (162 MHz, CD3CN): δ 26.636 (d, 1P, unsym PMe3), 23.805 (s, 4P, sym PMe3), 20.299 (s, 1P, unsym PMe3). IR (MeCN): νCO = 2048 (s), 2024 (m), 1985 (s) cm−1. ESI-MS: m/z = 557.2 (100%,M+), 529 (3%,M+ – CO), 501 (2%, M+ – 2CO).
References
- 1.Gloaguen F, Lawrence JD, Rauchfuss TB, Bénard M, Rohmer MM. Inorg Chem. 2002;41:6573–6582. doi: 10.1021/ic025838x. [DOI] [PubMed] [Google Scholar]
- 2.Zhao X, Georgakaki IP, Miller ML, Mejia-Rodriguez R, Chiang CY, Darensbourg MY. Inorg Chem. 2002;41:3917–3928. doi: 10.1021/ic020237r. [DOI] [PubMed] [Google Scholar]
- 3.Li P, Wang M, He C, Li G, Liu X, Chen C, Åkermark B, Sun L. Eur J Inorg Chem. 2005:2506–2513. [Google Scholar]
- 4.Lawrence JD, Rauchfuss TB, Wilson SR. Inorg Chem. 2002;41:6193–6195. doi: 10.1021/ic025919t. [DOI] [PubMed] [Google Scholar]
- 5.Boyke CA, Rauchfuss TB, Wilson SR, Rohmer MM, Benard M. J Am Chem Soc. 2004;126:15151–15160. doi: 10.1021/ja049050k. [DOI] [PubMed] [Google Scholar]
- 6.Tye JW, Lee J, Wang HW, Mejia-Rodriguez R, Reibenspies JH, Hall MB, Darensbourg MY. Inorg Chem. 2005;44:5550–5552. doi: 10.1021/ic050402d. [DOI] [PubMed] [Google Scholar]
- 7.Capon J-F, El Hassnaoui S, Gloaguen F, Schollhammer P, Talarmin J. Organometallics. 2005;24:2020–2022. [Google Scholar]
- 8.Duan L, Wang M, Li P, Na Y, Wang N, Sun L. Dalton Trans. 2007:1277–1283. doi: 10.1039/b616645h. [DOI] [PubMed] [Google Scholar]
- 9.Morvan D, Capon J-F, Gloaguen F, Le Go A, Marchivie M, Michaud F, Schollhammer P, Talarmin J, Yaouanc J-J, Pichon R, Kervarec N. Organometallics. 2007;26:2042–2052. [Google Scholar]
- 10.Schmidt M, Contakes SM, Rauchfuss TB. J Am Chem Soc. 1999;121:9736–9737. [Google Scholar]
- 11.Lyon EJ, Georgakaki IP, Reibenspies JH, Darensbourg MY. Angew Chem, Int Ed Engl. 1999;38:3178–3180. [PubMed] [Google Scholar]
- 12.Le Cloirec A, Davies SC, Evans DJ, Hughes DL, Pickett CJ, Best SP, Borg S. Chem Commun. 1999:2285–2286. [Google Scholar]
- 13.Razavet M, Borg SJ, George SJ, Best SP, Fairhurst SA, Pickett CJ. Chem Commun. 2002:700–701. doi: 10.1039/b111613b. [DOI] [PubMed] [Google Scholar]
- 14.Li H, Rauchfuss TB. J Am Chem Soc. 2002;124:726–727. doi: 10.1021/ja016964n. [DOI] [PubMed] [Google Scholar]
- 15.Lawrence JD, Li H, Rauchfuss TB. Chem Commun. 2001:1482–1483. [Google Scholar]
- 16.Lawrence JD, Li H, Rauchfuss TB, Benard M, Rohmer M-M. Angew Chem, Int Ed Engl. 2001;40:1768–1771. doi: 10.1002/1521-3773(20010504)40:9<1768::aid-anie17680>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
- 17.Jiang S, Liu J, Shi Y, Wang Z, Åkermark B, Sun L. Dalton Trans. 2007:896–902. doi: 10.1039/b615037c. [DOI] [PubMed] [Google Scholar]
- 18.Song L-C, Tang M-Y, Su F-H, Hu Q-M. Angew Chem, Int Ed. 2006;45:1130–1133. doi: 10.1002/anie.200503602. [DOI] [PubMed] [Google Scholar]
- 19.Volkers PI, Rauchfuss TB, Wilson SR. Eur J Inorg Chem. 2006:4793–4799. [Google Scholar]
- 20.Stanley JL, Rauchfuss TB, Wilson SR. Organometallics. 2007;26:1907–1911. doi: 10.1021/om0611150. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Das P, Capon JF, Gloaguen F, Pétillon FY, Schollhammer P, Talarmin J, Muir KW. Inorg Chem. 2004;43:8203–8205. doi: 10.1021/ic048772+. [DOI] [PubMed] [Google Scholar]
- 22.Cheah MH, Borg SJ, Bondin MI, Best SP. Inorg Chem. 2004;43:5635–5644. doi: 10.1021/ic049746e. [DOI] [PubMed] [Google Scholar]
- 23.Herberhold M, Leonhard K. J Organomet Chem. 1974;78:253–263. [Google Scholar]
- 24.Herberhold M, Leonhard K, Wagner U, Wagner FE, Danon J. J Chem Soc, Dalton Trans. 1979:654–657. [Google Scholar]
- 25.Doedens RJ. Inorg Chem. 1970;9:429–436. [Google Scholar]
- 26.Ellgen PC, Gerlach JN. Inorg Chem. 1974;13:1944–1947. [Google Scholar]
- 27.Bennett RP. Inorg Chem. 1970;9:2184–2186. [Google Scholar]
- 28.Ellgen PC, McMullin SL. Inorg Chem. 1973;12:2004–2007. [Google Scholar]
- 29.Gloaguen F, Lawrence JD, Schmidt M, Wilson SR, Rauchfuss TB. J Am Chem Soc. 2001;123:12518–12527. doi: 10.1021/ja016071v. [DOI] [PubMed] [Google Scholar]
- 30.Gloaguen F, Lawrence JD, Rauchfuss TB. J Am Chem Soc. 2001;123:9476–9477. doi: 10.1021/ja016516f. [DOI] [PubMed] [Google Scholar]
- 31.Chong D, Georgakaki IP, Mejia-Rodriguez R, Sanabria-Chinchilla J, Soriaga MP, Darensbourg MY. Dalton Trans. 2003:4158–4163. [Google Scholar]
- 32.Zhao X, Georgakaki IP, Miller ML, Yarbrough JC, Darensbourg MY. J Am Chem Soc. 2001;123:9710–9711. doi: 10.1021/ja0167046. [DOI] [PubMed] [Google Scholar]
- 33.Ellgen PC, Gerlach JN. Inorg Chem. 1973;12:2526–2532. [Google Scholar]
- 34.Justice AK, Linck RC, Rauchfuss TB. Inorg Chem. 2006;45:2406–2412. doi: 10.1021/ic051989z. [DOI] [PubMed] [Google Scholar]
- 35.Bjorsvik HR, Gonzalez RR, Liguori L. J Org Chem. 2004;69:7720–7727. doi: 10.1021/jo049102o. [DOI] [PubMed] [Google Scholar]
- 36.Aime S, Gervasio G, Milone L, Rossetti R, Stanghellini PL. J Chem Soc, Dalton Trans. 1978:534–540. [Google Scholar]
- 37.Dahl LF, Costello WR, King RB. J Am Chem Soc. 1968;90:5422–5429. [Google Scholar]
- 38.Little RG, Doedens RJ. Inorg Chem. 1972;11:1392–1397. [Google Scholar]
- 39.Hansert B, Vahrenkamp H. J Organomet Chem. 1993;459:265–269. [Google Scholar]
- 40.Kabir SE, Ruf M, Vahrenkamp H. J Organomet Chem. 1996;512:261–263. [Google Scholar]
- 41.Kabir SE, Ruf M, Vahrenkamp H. J Organomet Chem. 1998;571:91–96. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supplementary data associated with this article can be found, in the online version, at doi:10.1016/j.jinorgbio.2007. 05.005.

